Abstract
In this study, we prepared two different type complex groups. One of them is based on Schiff base (A1 , A2 and A3) Cd(II) complexes, another one is β-blockers (acebutolol (ACE), atenolol (ATE) and propranolol (PRO)) Cu(II) complexes. The ligands and their metal complexes were characterized by elemental analyses, mass spectra, 1H(13C) NMR spectra, FT-IR, UV-vis, conductivity measurements and thermal analysis studies. Protonation constants of the ligands and stability constants of their complexes were determined by potentiometric titration method at 25.00±0.02 oC under nitrogen atmosphere and ionic strength of 0.10 M sodium perchlorate. For the Schiff bases, the solvent was 50% DMSO – water; for the β-blockers, it was 50% methanol-water media. The effects of these properties on the observed inhibition of chemiluminescence and the analytical implications of the results are also discussed. Two sets of novel coordination compounds were found to inhibit the intense chemiluminescence reaction in DMSO solution between luminol and dioxygen in the presence of a strong base.
Keywords: Schiff base ligands, Complexes, β-blockers, Stability Constants, Potentiometric studies, Luminol chemiluminescence
Current Analytical Chemistry
Title: Investigations into the Inhibition of Luminol Chemiluminescence by some Novel Metal Complexes
Volume: 6 Issue: 2
Author(s): Aysegul Golcu, R. Alan Wheatley, Havva Demirelli, Mehmet Tumer and Mustafa Dolaz
Affiliation:
Keywords: Schiff base ligands, Complexes, β-blockers, Stability Constants, Potentiometric studies, Luminol chemiluminescence
Abstract: In this study, we prepared two different type complex groups. One of them is based on Schiff base (A1 , A2 and A3) Cd(II) complexes, another one is β-blockers (acebutolol (ACE), atenolol (ATE) and propranolol (PRO)) Cu(II) complexes. The ligands and their metal complexes were characterized by elemental analyses, mass spectra, 1H(13C) NMR spectra, FT-IR, UV-vis, conductivity measurements and thermal analysis studies. Protonation constants of the ligands and stability constants of their complexes were determined by potentiometric titration method at 25.00±0.02 oC under nitrogen atmosphere and ionic strength of 0.10 M sodium perchlorate. For the Schiff bases, the solvent was 50% DMSO – water; for the β-blockers, it was 50% methanol-water media. The effects of these properties on the observed inhibition of chemiluminescence and the analytical implications of the results are also discussed. Two sets of novel coordination compounds were found to inhibit the intense chemiluminescence reaction in DMSO solution between luminol and dioxygen in the presence of a strong base.
Export Options
About this article
Cite this article as:
Golcu Aysegul, Wheatley Alan R., Demirelli Havva, Tumer Mehmet and Dolaz Mustafa, Investigations into the Inhibition of Luminol Chemiluminescence by some Novel Metal Complexes, Current Analytical Chemistry 2010; 6 (2) . https://dx.doi.org/10.2174/157341110790945526
DOI https://dx.doi.org/10.2174/157341110790945526 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Indian Spices for Healthy Heart - An Overview
Current Cardiology Reviews Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews Red Wine Consumption and Prevention of Atherosclerosis: An In Vitro Model Using Human Peripheral Blood Mononuclear Cells
Current Pharmaceutical Design Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases
Current Topics in Medicinal Chemistry Therapeutic Strategies in the Treatment of Diabetic Nephropathy - a Translational Medicine Approach
Current Medicinal Chemistry Quantitative Analysis of Uric Acid Metabolites in Urine by High Performance Liquid Chromatography - Mass Spectrometry Using Silica Hydride Columns
Current Chromatography Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials
Current Hypertension Reviews Role of Granulocyte-colony Stimulating Factor in the Protection of Cerebral Vascular Endothelium, White Matter, and Cognition
Current Neurovascular Research Clinical Evidence and Therapeutic Treatments at the Time of the Coronaviruses Responsible for SARS: A Perspective and Points of view with a Focus on Vascular Endothelium
Coronaviruses Sonoelastography for Pelvic Metastatic Malignant Pheochromocytoma: A Case Report
Current Medical Imaging Pharmacological Therapies for Pediatric and Neonatal ALI/ARDS: An Evidence-Based Review
Current Drug Targets Strain and Strain Rate Imaging by Echocardiography - Basic Concepts and Clinical Applicability
Current Cardiology Reviews p66 Shc as the Engine of Vascular Aging
Current Vascular Pharmacology Placental Cytokines in the Pathogenesis of Preeclampsia and Hellp Syndrome
Current Women`s Health Reviews Cellular and Pharmacological Targets to Induce Coronary Arteriogenesis
Current Cardiology Reviews Recent Drug Development Approaches in Thrombosis, Stroke and other Cardiovascular Diseases
Current Pharmaceutical Design Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
Current Pharmaceutical Design Natural Products, the Continuous Source of Therapeutic Molecules for Various Diseases: Literature Landscape Analysis
Current Molecular Pharmacology The Role of the Heme Oxygenase System in the Metabolic Syndrome
Current Pharmaceutical Design The Chromogranin A-Derived Vasostatins: New Players in the Endocrine Heart
Current Medicinal Chemistry